Srilatha Swami

4.7k total citations · 1 hit paper
38 papers, 3.4k citations indexed

About

Srilatha Swami is a scholar working on Genetics, Pathology and Forensic Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Srilatha Swami has authored 38 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Genetics, 23 papers in Pathology and Forensic Medicine and 8 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Srilatha Swami's work include Estrogen and related hormone effects (23 papers), Vitamin D Research Studies (21 papers) and Inflammatory mediators and NSAID effects (7 papers). Srilatha Swami is often cited by papers focused on Estrogen and related hormone effects (23 papers), Vitamin D Research Studies (21 papers) and Inflammatory mediators and NSAID effects (7 papers). Srilatha Swami collaborates with scholars based in United States, Australia and Finland. Srilatha Swami's co-authors include David Feldman, Aruna V. Krishnan, Brian J. Feldman, Edward L. Giovannucci, Donna M. Peehl, Jacqueline Moreno, Peter J. Malloy, Xiao-Yan Zhao, Nora M. Navone and Megan A. Albertelli and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and Nature reviews. Cancer.

In The Last Decade

Srilatha Swami

38 papers receiving 3.3k citations

Hit Papers

The role of vitamin D in ... 2014 2026 2018 2022 2014 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The role of vitamin D in reducing cancer risk and progression
    2014 989 citations David Feldman, Aruna V. Krishnan et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Srilatha Swami United States 28 1.8k 997 823 779 601 38 3.4k
Kay W. Colston United Kingdom 34 2.1k 1.1× 1.1k 1.1× 1.0k 1.2× 988 1.3× 254 0.4× 59 3.8k
María Jesús Larriba Spain 31 1.4k 0.8× 732 0.7× 1.3k 1.6× 818 1.1× 160 0.3× 55 2.9k
Toshimasa Shinki Japan 31 1.6k 0.9× 554 0.6× 1.3k 1.5× 549 0.7× 127 0.2× 67 3.1k
Kristin K. Deeb United States 12 950 0.5× 352 0.4× 546 0.7× 362 0.5× 148 0.2× 29 1.8k
Karen Curtin United States 41 2.5k 1.4× 746 0.7× 1.7k 2.0× 2.9k 3.7× 657 1.1× 137 5.8k
Mingjun Shi China 26 573 0.3× 1.2k 1.2× 1.2k 1.4× 180 0.2× 379 0.6× 64 4.1k
Robert U. Simpson United States 28 2.0k 1.1× 296 0.3× 640 0.8× 165 0.2× 231 0.4× 62 3.0k
Jean M. Prahl United States 28 2.1k 1.1× 948 1.0× 783 1.0× 197 0.3× 101 0.2× 47 2.8k
June E. Bishop United States 26 1.7k 0.9× 747 0.7× 646 0.8× 207 0.3× 125 0.2× 48 2.5k
Sunil Nagpal United States 19 763 0.4× 491 0.5× 544 0.7× 253 0.3× 84 0.1× 29 2.1k

Countries citing papers authored by Srilatha Swami

Since Specialization
Citations

This map shows the geographic impact of Srilatha Swami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Srilatha Swami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Srilatha Swami more than expected).

Fields of papers citing papers by Srilatha Swami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Srilatha Swami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Srilatha Swami. The network helps show where Srilatha Swami may publish in the future.

Co-authorship network of co-authors of Srilatha Swami

This figure shows the co-authorship network connecting the top 25 collaborators of Srilatha Swami. A scholar is included among the top collaborators of Srilatha Swami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Srilatha Swami. Srilatha Swami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Swami, Srilatha, et al.. (2023). Parathyroid hormone 1 receptor signaling mediates breast cancer metastasis to bone in mice. JCI Insight. 8(5). 10 indexed citations
2.
3.
Swami, Srilatha, Joshua Johnson, Takaharu Kimura, et al.. (2017). Prevention of breast cancer skeletal metastases with parathyroid hormone. JCI Insight. 2(17). 37 indexed citations
4.
Swami, Srilatha, Aruna V. Krishnan, Abhishek Aggarwal, et al.. (2016). Vitamin D mitigates the adverse effects of obesity on breast cancer in mice. Endocrine Related Cancer. 23(4). 251–264. 42 indexed citations
5.
Jeong, Youngtae, Srilatha Swami, Aruna V. Krishnan, et al.. (2015). Inhibition of Mouse Breast Tumor-Initiating Cells by Calcitriol and Dietary Vitamin D. Molecular Cancer Therapeutics. 14(8). 1951–1961. 46 indexed citations
6.
Sinha, Partha, Piia Aarnisalo, Ingrid J. Poulton, et al.. (2015). Loss of Gsα in the Postnatal Skeleton Leads to Low Bone Mass and a Blunted Response to Anabolic Parathyroid Hormone Therapy. Journal of Biological Chemistry. 291(4). 1631–1642. 35 indexed citations
7.
Krishnan, Aruna V., Srilatha Swami, & David Feldman. (2012). The potential therapeutic benefits of vitamin D in the treatment of estrogen receptor positive breast cancer. Steroids. 77(11). 1107–1112. 68 indexed citations
8.
Wang, Jennifer Y., Srilatha Swami, Aruna V. Krishnan, & David Feldman. (2012). Combination of calcitriol and dietary soy exhibits enhanced anticancer activity and increased hypercalcemic toxicity in a mouse xenograft model of prostate cancer. The Prostate. 72(15). 1628–1637. 21 indexed citations
9.
Krishnan, Aruna V., Srilatha Swami, & David Feldman. (2012). Equivalent anticancer activities of dietary vitamin D and calcitriol in an animal model of breast cancer: Importance of mammary CYP27B1 for treatment and prevention. The Journal of Steroid Biochemistry and Molecular Biology. 136. 289–295. 37 indexed citations
10.
Swami, Srilatha, Aruna V. Krishnan, Jennifer Y. Wang, et al.. (2011). Inhibitory Effects of Calcitriol on the Growth of MCF-7 Breast Cancer Xenografts in Nude Mice: Selective Modulation of Aromatase Expression in vivo. Hormones and Cancer. 2(3). 190–202. 51 indexed citations
11.
Swami, Srilatha, Aruna V. Krishnan, & David Feldman. (2011). Vitamin D metabolism and action in the prostate: Implications for health and disease. Molecular and Cellular Endocrinology. 347(1-2). 61–69. 48 indexed citations
12.
Feldman, David, Aruna V. Krishnan, Jacqueline Moreno, et al.. (2008). Vitamin D Inhibition of the Prostaglandin Pathway as Therapy for Prostate Cancer. Nutrition Reviews. 65(8 Pt 2). S113–S115. 22 indexed citations
13.
Krishnan, Aruna V., Jacqueline Moreno, Larisa Nonn, et al.. (2007). Novel pathways that contribute to the anti-proliferative and chemopreventive activities of calcitriol in prostate cancer. The Journal of Steroid Biochemistry and Molecular Biology. 103(3-5). 694–702. 70 indexed citations
14.
Swami, Srilatha, et al.. (2007). Calcitriol and Genistein Actions to Inhibit the Prostaglandin Pathway: Potential Combination Therapy to Treat Prostate Cancer ,3. Journal of Nutrition. 137(1). 205S–210S. 44 indexed citations
15.
Krishnan, Aruna V., et al.. (2007). Potentiation of the Growth-Inhibitory Effects of Vitamin D in Prostate Cancer by Genistein. Nutrition Reviews. 65(8). 121–123. 12 indexed citations
16.
Swami, Srilatha, Aruna V. Krishnan, Donna M. Peehl, & David Feldman. (2005). Genistein potentiates the growth inhibitory effects of 1,25-dihydroxyvitamin D3 in DU145 human prostate cancer cells: Role of the direct inhibition of CYP24 enzyme activity. Molecular and Cellular Endocrinology. 241(1-2). 49–61. 67 indexed citations
17.
Swami, Srilatha, Nalini Raghavachari, Uwe R. Müller, Yijia Bao, & David Feldman. (2003). Vitamin D Growth Inhibition of Breast Cancer Cells: Gene Expression Patterns Assessed by cDNA Microarray. Breast Cancer Research and Treatment. 80(1). 49–62. 161 indexed citations
18.
19.
Swami, Srilatha, Aruna V. Krishnan, & David Feldman. (2000). 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.. PubMed. 6(8). 3371–9. 132 indexed citations
20.
Swami, Srilatha, et al.. (1995). E-cadherin expression in gastroesophageal reflux disease, Barrett's esophagus, and esophageal adenocarcinoma: an immunohistochemical and immunoblot study.. PubMed. 90(10). 1808–13. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kay W. Colston Breakdown of academic impact, for papers by María Jesús Larriba Breakdown of academic impact, for papers by Toshimasa Shinki Breakdown of academic impact, for papers by Kristin K. Deeb Breakdown of academic impact, for papers by Karen Curtin Breakdown of academic impact, for papers by Mingjun Shi Breakdown of academic impact, for papers by Robert U. Simpson Breakdown of academic impact, for papers by Jean M. Prahl Breakdown of academic impact, for papers by June E. Bishop Breakdown of academic impact, for papers by Sunil Nagpal
Rankless by CCL
2026